AGL 6.45 Decreased By ▼ -0.05 (-0.77%)
ANL 9.50 Decreased By ▼ -0.20 (-2.06%)
AVN 74.95 Decreased By ▼ -0.88 (-1.16%)
BOP 5.35 Increased By ▲ 0.03 (0.56%)
CNERGY 4.80 Decreased By ▼ -0.05 (-1.03%)
EFERT 78.00 Increased By ▲ 0.51 (0.66%)
EPCL 54.15 Decreased By ▼ -1.06 (-1.92%)
FCCL 15.00 Decreased By ▼ -0.25 (-1.64%)
FFL 6.20 Decreased By ▼ -0.10 (-1.59%)
FLYNG 7.01 Increased By ▲ 0.16 (2.34%)
GGGL 10.05 Decreased By ▼ -0.12 (-1.18%)
GGL 15.94 Decreased By ▼ -0.37 (-2.27%)
GTECH 7.85 Increased By ▲ 0.41 (5.51%)
HUMNL 6.27 Decreased By ▼ -0.06 (-0.95%)
KEL 2.83 Decreased By ▼ -0.14 (-4.71%)
LOTCHEM 27.65 Decreased By ▼ -0.65 (-2.3%)
MLCF 27.00 Decreased By ▼ -0.56 (-2.03%)
OGDC 73.35 Decreased By ▼ -0.65 (-0.88%)
PAEL 15.30 Decreased By ▼ -0.29 (-1.86%)
PIBTL 5.15 Decreased By ▼ -0.10 (-1.9%)
PRL 16.10 Decreased By ▼ -0.48 (-2.9%)
SILK 1.04 Decreased By ▼ -0.02 (-1.89%)
TELE 10.45 Decreased By ▼ -0.20 (-1.88%)
TPL 7.69 Decreased By ▼ -0.19 (-2.41%)
TPLP 19.22 Decreased By ▼ -0.48 (-2.44%)
TREET 22.75 Decreased By ▼ -0.25 (-1.09%)
TRG 115.90 Decreased By ▼ -4.20 (-3.5%)
UNITY 21.80 Decreased By ▼ -0.34 (-1.54%)
WAVES 11.15 Decreased By ▼ -0.05 (-0.45%)
WTL 1.12 Decreased By ▼ -0.03 (-2.61%)
BR100 4,039 Decreased By -56.1 (-1.37%)
BR30 14,984 Decreased By -242.5 (-1.59%)
KSE100 40,620 Decreased By -307.7 (-0.75%)
KSE30 15,213 Decreased By -142.6 (-0.93%)
Business & Finance

Moderna to deliver 25 million COVID-19 vaccine doses to Australia

  • It has been trying to speed up the rollout of jabs after it was stalled by supply hold-ups in Europe and concerns about blood clots tied to the AstraZeneca shot.
  • The deal also includes the supply of 15 million doses of Moderna's updated variant booster vaccine candidate to be delivered in 2022, the company said.
Published May 12, 2021
Follow us

Moderna Inc will supply Australia 25 million doses of its COVID-19 vaccine, of which 10 million doses against the original strain of the virus will be delivered this year, the drugmaker said on Wednesday.

Australia currently has two authorized vaccines from Pfizer-BioNTech and AstraZeneca.

It has been trying to speed up the rollout of jabs after it was stalled by supply hold-ups in Europe and concerns about blood clots tied to the AstraZeneca shot.

The deal also includes the supply of 15 million doses of Moderna's updated variant booster vaccine candidate to be delivered in 2022, the company said.

The pact with Moderna is subject to regulatory approval of its vaccine candidate, which is authorized for emergency use in individuals 18 years of age or older in the United States.

Moderna has also received authorization for its vaccine from health agencies including Canada, Israel, the European Union, the United Kingdom and Switzerland.

Comments

Comments are closed.